U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C36H56N2O4.ClH
Molecular Weight 617.302
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DAGAPAMIL HYDROCHLORIDE

SMILES

Cl.CCCCCCCCCCCCC(CCCN(C)CCC1=CC=CC(OC)=C1)(C#N)C2=CC(OC)=C(OC)C(OC)=C2

InChI

InChIKey=UFADIJNJESEOGE-UHFFFAOYSA-N
InChI=1S/C36H56N2O4.ClH/c1-7-8-9-10-11-12-13-14-15-16-22-36(29-37,31-27-33(40-4)35(42-6)34(28-31)41-5)23-18-24-38(2)25-21-30-19-17-20-32(26-30)39-3;/h17,19-20,26-28H,7-16,18,21-25H2,1-6H3;1H

HIDE SMILES / InChI

Description

Dagapamil is a calcium-channel blocker, discovered by BASF. The compound is claimed to have antihypertensive, antiarrhythmic, cardioprotective, antiallergic and platelet aggregation-inhibiting action in animal models.

Approval Year

Unknown
149124
Name Type Language
BENZENEACETONITRILE, .ALPHA.-DODECYL-3,4,5-TRIMETHOXY-.ALPHA.-(3-((2-(3-METHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-, HYDROCHLORIDE (1:1)
Preferred Name English
DAGAPAMIL HYDROCHLORIDE
Common Name English
BENZENEACETONITRILE, .ALPHA.-DODECYL-3,4,5-TRIMETHOXY-.ALPHA.-(3-((2-(3-METHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-, MONOHYDROCHLORIDE
Systematic Name English
Code System Code Type Description
CAS
85246-70-4
Created by admin on Mon Mar 31 23:42:00 GMT 2025 , Edited by admin on Mon Mar 31 23:42:00 GMT 2025
PRIMARY
FDA UNII
4UQ8B10R65
Created by admin on Mon Mar 31 23:42:00 GMT 2025 , Edited by admin on Mon Mar 31 23:42:00 GMT 2025
PRIMARY
PUBCHEM
13647723
Created by admin on Mon Mar 31 23:42:00 GMT 2025 , Edited by admin on Mon Mar 31 23:42:00 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of DAGAPAMIL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966